CLS Holdings USA Inc. (OTCMKTS:CLSH) Share price Stays Strong Despite DOJ Comments

Last week a fund of marijuana-based stocks dropped more than 9 percent in value and, as a sign of how mainstream marijuana has become. Most shares dipped only intraday after the DOJ commented that the feds and the states are not finished butting heads over recent widespread legalization.

Last Thursday may well turn out to be a pivotal moment in the marijuana industry’s evolution as a political force. Nearly 70 percent of Americans believe in some form of legalized marijuana, but does the nascent industry have the sway to rewrite nearly 50 years of federal drug policy? Or will it remain a splintered coalition of investors, libertarians, concerned parents of sick kids, cancer sufferers, and traumatized veterans, who have the numbers but not the concentrated lobbying effort necessary to once and for all remove marijuana from the crosshairs of federal drug enforcement?

Stock Analysis

A push by the company to strengthen its cannabis production capabilities appears to have strengthened investors’ confidence on its long-term prospects. The stock is currently trading in an uptrend after gaining more than 50% in response to recent positive news.

For the full year, CLS Holdings USA Inc. (OTCMKTS:CLSH) is up by more than 80%. Given the strength of the upward momentum, the stock should be able to register a new 52-week high as it is currently trading in tight $0.70 to $0.75 range. Lower immediate support looks to be the $0.60 mark. CLS Holdings USA Inc. (OTCMKTS:CLSH) closed the year just off the December high of $0.94 as it continues to affirm plans to double its cannabis growth production capacity.

Recent News

Jan 8…  Here’s the comments from management that was released today regarding the comments from AG Jeff Sessions: http://www.marketwired.com/press-release/cls-holdings-usa-comments-on-recent-department-of-justice-guidance-otcqb-clsh-2244191.htm

Jan 3 … The company announced that it has received a notice of allowance from the U.S. patent office for its proprietary extraction and conversion methodology.

The proprietary extraction process differs from others that typically use ethanol, supercritical CO2 or butane. The resulting finished product is cleaner and provides for more Delta 9 THC. The Company intends to deploy its proprietary extraction and conversion technology upon completion of its pending acquisition of Oasis Cannabis. Additionally, the Company will look to license its patented extraction process.

Jeff Binder, Chairman and CEO of CLS, stated, “Extraction is a very important and valuable process as the quality and value of the finished product is largely impacted by the quality of its extraction. We are focused on increasing yields and the quality of yields and feel our process gives us a major leg up relative to others in the industry. We have dedicated considerable amounts of resources to this endeavor and to receive this allowance from the US patent office is a milestone for the company. I am truly appreciative of all the efforts and contributions of our team and wish to personally thank our chief scientist and co-founder, Ray Keller.”

Acquisition
Dec. 11… Oasis is an exciting acquisition target as it is set to expand CLS Holdings USA Inc. (OTCMKTS:CLSH) footprint in the business of growing, extracting and processing cannabis products for retail. The company comes into the deal with a growing, conversion and extraction facility that produced $150,000 in gross revenue last month.

The acquisition should be of great benefit to CLS Holdings on the fact that Oasis already generates revenues and has permits to operate dispensaries and deliver products to end consumers.
The parent company also stands to use its proprietary extraction methods to increase the yields from Oasis grow and cultivation businesses. CLSH may also scale Oasis retail business by opening franchises throughout Nevada as well as in other states that have approved marijuana sale.

In addition, the company’s cash balance destined to receive a significant boost upon the closing of the definitive acquisition agreement given that Oasis dispensary serves over 300 customers on a daily basis.
“Since we began this process to acquire Oasis Cannabis a couple of months ago, we have witnessed firsthand its growth and traction in visitors and revenue. We are very pleased with the trends at its grow and retail dispensary and are enthusiastic to move forward to an anticipated closing in the first quarter of 2018,” said CEO, Jeff Binder.

Management Appointment

The appointment of, David Lamadrid, as the President and Chief Financial Officer appears to have strengthened investor confidence in CLS Holdings USA Inc. (OTCMKTS:CLSH). He joins the company with vast experience in management and finance required to lead the firm through the next phase of growth.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $CLSH and receive breaking news on other hot stocks by signing up for our free newsletter!

FacebookTwitterGoogle+PinterestLinkedIn
acquisitionbiotechcannabiscls holdingsmerger
PREVIOUS ARTICLE
CELLECTAR (NASDAQ: CLRB) JUMPS 35% ON EXPANSION OF PHASE 2 TRIAL

Monica Gray
Monica has an undergraduate degree in Accounting and an MBA she earned – with Honors. She has six years of experience in the financial markets and has been an analyst for the past two years.
Leave a Reply
YOUR EMAIL ADDRESS WILL NOT BE PUBLISHED. REQUIRED FIELDS ARE MARKED *

Comment

Name *

Email *

Website

POST COMMENT

AURORA CANNABIS IN (OTCMKTS:ACBFF)

CLS Holdings USA (OTCMKTS:CLSH) Receives a Notice of Allowance from the U.S. Patent Office.

Shares of CLS Holdings USA Inc. (OTCMKTS:CLSH) are trading higher in the wake of the company announcing that it has received a notice of allowance from the U.S. patent office for its proprietary extraction and conversion methodology.

The proprietary extraction process differs from others that typically use ethanol, supercritical CO2 or butane. The resulting finished product is cleaner and provides for more Delta 9 THC. The Company intends to deploy its proprietary extraction and conversion technology upon completion of its pending acquisition of Oasis Cannabis. Additionally, the Company will look to license its patented extraction process.

Jeff Binder, Chairman and CEO of CLS, stated, “Extraction is a very important and valuable process as the quality and value of the finished product is largely impacted by the quality of its extraction. We are focused on increasing yields and the quality of yields and feel our process gives us a major leg up relative to others in the industry. We have dedicated considerable amounts of resources to this endeavor and to receive this allowance from the US patent office is a milestone for the company. I am truly appreciative of all the efforts and contributions of our team and wish to personally thank our chief scientist and co-founder, Ray Keller.”

Stock Analysis

A push by the company to strengthen its cannabis production capabilities appears to have strengthened investors’ confidence on its long-term prospects. The stock is currently trading in an uptrend after gaining more than 50% in response to recent positive news.

For the full year, CLS Holdings USA Inc. (OTCMKTS:CLSH) is up by more than 80%. Given the strength of the upward momentum, the stock should be able to register a new 52-week high as it is currently trading in tight $0.64 to $0.69 range. Lower immediate support looks to be the $0.45 mark. CLS Holdings USA Inc. (OTCMKTS:CLSH) should close the year on the high as it continues to affirm plans to double its cannabis growth production capacity.

Recent Oasis Cannabis Acquisition News

Oasis is an exciting acquisition target as it is set to expand CLS Holdings USA Inc. (OTCMKTS:CLSH) footprint in the business of growing, extracting and processing cannabis products for retail. The company comes into the deal with a growing, conversion and extraction facility that produced $150,000 in gross revenue last month.

The acquisition should be of great benefit to CLS Holdings on the fact that Oasis already generates revenues and has permits to operate dispensaries and deliver products to end consumers.
The parent company also stands to use its proprietary extraction methods to increase the yields from Oasis grow and cultivation businesses. CLSH may also scale Oasis retail business by opening franchises throughout Nevada as well as in other states that have approved marijuana sale.

In addition, the company’s cash balance destined to receive a significant boost upon the closing of the definitive acquisition agreement given that Oasis dispensary serves over 300 customers on a daily basis.
“Since we began this process to acquire Oasis Cannabis a couple of months ago, we have witnessed firsthand its growth and traction in visitors and revenue. We are very pleased with the trends at its grow and retail dispensary and are enthusiastic to move forward to an anticipated closing in the first quarter of 2018,” said CEO, Jeff Binder.

Management Appointment

The appointment of, David Lamadrid, as the President and Chief Financial Officer appears to have strengthened investor confidence in CLS Holdings USA Inc. (OTCMKTS:CLSH). He joins the company with vast experience in management and finance required to lead the firm through the next phase of growth.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $CLSH and receive breaking news on other hot stocks by signing up for our free newsletter!

AURORA CANNABIS IN (OTCMKTS:ACBFF)

Debt Conversion By AURORA CANNABIS IN (OTCMKTS:ACBFF) Brings Sellers

AURORA CANNABIS IN (OTCMKTS:ACBFF)

AURORA CANNABIS IN (OTCMKTS:ACBFF) has announced the conversion into common shares of the outstanding amount with regards to the remaining debentures and this will be effective next month. In absolute terms debentures outstanding which are valued at $73,593,000 will be converted into common shares numbering 22,368,693. After the announcement shares of Aurora Cannabis Inc fell by 13%.

AURORA CANNABIS IN (OTCMKTS:ACBFF)

According to the chief executive officer of AURORA CANNABIS IN (OTCMKTS:ACBFF), Terry Booth, the move will strengthen the company’s financial position allow it to execute an aggressive global expansion strategy.

“This conversion reflects our exceptional execution … We will be generating over $5 million in interest savings on an annual basis, while removing nearly $75 million in liabilities from our balance sheet,” Booth said.

Annual General Meeting

The announcement comes in the wake of Aurora releasing the voting results following the 2017 annual general meeting which was held on November 13 in Edmonton, Canada. During the AGM shareholders approved the matters that were contained in Aurora’s Management Information Circular – issued on October 6. Additionally, the shareholders approved MNP LLP being reappointed as the company’s auditors for the coming year.

During the AGM new directors were voted onto Aurora’s Board of Directors. The appointments include Diane Jang who also serves as the Chief Executive Officer of Hempco Food and Fiber. Jang has close to three decades worth of experience in the consumer-packaged goods sector. Before joining Hempco as the CEO, Jang was the president of Sunrise Soya Foods as well as the general manager of Earth’s Own Food.

Aurora’s Shareholders Meeting

AURORA CANNABIS IN (OTCMKTS:ACBFF) recently made an investment in Hempco which was approved by shareholders in a special meeting. After the investment, Aurora’s shareholding in Hempco will rise to more than 50%.

AURORA CANNABIS IN (OTCMKTS:ACBFF)’s AGM had been preceded by the release of Q1 2018 financial results. In the report Aurora indicated that the company now has more than 20,000 registered patients who are active. Revenues for the quarter increased by 169% year-over-year to reach a figure of $8.2 million. Revenues rose 39% compared to the previous quarter. Most of the revenue was generated in Canada with North American dried cannabis sales comprising more than half of the total sales.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $ACBFF and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.

Singlepoint Inc (OTCMKTS:SING)

Singlepoint Inc (OTCMKTS:SING) Invests in Dr. FeelGood and WeedCoin

Singlepoint Inc (OTCMKTS:SING)

Shares of Singlepoint Inc (OTCMKTS:SING) rallied 20.20% after the company confirmed the acquisition of Dr. FeelGood, a profitable cannabis distribution company. Under the terms of the agreement, the company is to acquire a 51% stake in the distribution firm in a cash and stock transaction.

The 20.20% rally helped reverse a sell-off wave that had already broken a key support level. Singlepoint Inc (OTCMKTS:SING) is currently trading in a $0.06-$0.07 trading range, waiting to see if it will break through the $0.08 – $0.09 levels, which are acting as immediate resistance levels.

Singlepoint Inc (OTCMKTS:SING)
One month SING stock price chart

The Dr. FeelGood acquisition has already triggered renewed investor interest in Singlepoint Inc (OTCMKTS:SING) stock given that it strengthens the company’s prospects in the multibillion legal cannabis business. Dr. FeelGood is SinglePoint’s third acquisition for the year as it continues to diversify its revenue stream through acquisitions.

Revenue Addition

Dr. FeelGood should provide Singlepoint Inc. (OTCMKTS:SING) with additional revenue, in addition to an experienced team that has been working in the cannabis industry for years. The distribution firm is currently working on a mobile app that, it claims, will enhance their user experience in addition to streamlining operations.

“SinglePoint is in a better position than it has ever been before. We are well capitalized to continue acquisitions and we are optimistic to complete additional acquisitions and very optimistic to significantly increase the company revenue,” said Singlepoint Inc (OTCMKTS:SING) CEO, Greg Lambrecht.

Dr. FeelGood boasts of a wide variety of products distributed through B2B and B2C channels that Singlepoint Inc (OTCMKTS:SING) is set to gain access to. The two companies are also set to collaborate on the development and implementation of a new delivery platform.

WeedCoin Acquisition

Singlepoint Inc (OTCMKTS:SING) has also completed the acquisition of WeedCoin from First Bitcoin Capital Inc. The acquisition expands the company’s footprint into the Bitcoin business. WeedCoin is one of the three Cryptocurrencies targeting consumers in the cannabis business. Since its launch, the cryptocurrency has achieved a market capitalization of $60 million.

By acquiring WeedCoin, Singlepoint Inc. (OTCMKTS:SING) hopes to provide customers an alternative payment option given the many barriers that come into play with traditional payment options. WeedCoin is already registered in three popular exchanges which could see it generate greater levels of interest needed to gain a competitive edge against other Cryptocurrencies.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $SING and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Monica has an undergraduate degree in Accounting and an MBA she earned – with Honors. She has six years of experience in the financial markets and has been an analyst for the past two years.

Pharmacyte Biotech Inc (OTCMKTS:PMCB)

Pharmacyte Biotech Inc (OTCMKTS:PMCB) and Austrianova Sign New Terms

Pharmacyte Biotech Inc (OTCMKTS:PMCB)

Pharmacyte Biotech Inc (OTCMKTS:PMCB) has reached an agreement with Austrianova for the restructuring of certain agreements, pursuant to a previously agreed binding Term Sheet. Investors reacted to the news by sending the stock up.

Shares of Pharmacyte Biotech Inc (OTCMKTS:PMCB) are currently trading in a downtrend in a $0.05 – $0.06 trading range. The stock faces immediate support at the $0.05 mark below which it could register a new 2017 low. Its 52-week low is $0.02, registered last year.

Pharmacyte Biotech Inc (OTCMKTS:PMCB)
One month PMCB stock price chart

Pharmacyte Biotech Inc (OTCMKTS:PMCB) is a clinical stage biotechnology company, focused on the development of treatments for cancer and diabetes. The company also boasts of a Cell-in-a-Box technology acquired as part of a Binding Term Sheet with Austrianova.

Binding Term Sheet Terms

The restructuring of the binding Term Sheet, according to CEO Kenneth L Waggoner, should make it easier for the company to achieve its long term goals. Under the new terms, PharmaCyte will not make any milestone payments under the Asset Purchase agreement, Diabetes Licensing agreement, or the Cannabis Licensing Agreement.

The new terms also reduce the amount of royalty fees and sub-licensing royalty fees that the company will have to make. The new binding Term Sheet also provides PharmaCyte with a year of right-of-first-refusal should Austrianova choose to sell, assign, or transfer Cell-in-a-Box, Intellectual Property, or trade secrets.

“Not only has Austrianova made significant financial concessions, Austrianova has agreed to provide us with a vehicle by which we can acquire Cell-in-a-Box® and its Associated Technologies, including the manufacturing facility that will encapsulate the live cells required for our pancreatic cancer therapy and the other therapies we are developing,” said Mr. Waggoner.

Austrianova has also agreed not to solicit, negotiate, or entertain any inquiry regarding the sale of the Cell-in-a-Box and associated technologies. The Clinical stage biopharmaceutical company has also agreed to share with Austrianova 50% of any financial and non-financial consideration it receives under the asset purchase agreement. Pharmacyte Biotech Inc (OTCMKTS:PMCB) is also to pay Austrianova $150,000 over the next 6 months.

The chief executive officer expects the new binding Term Sheet to strengthen the partnership that has existed between Pharmacyte Biotech Inc (OTCMKTS:PMCB) and Austrianova since it bought the Cell-in-Box technology.

Pharmacyte Biotech Management Appointment

Separately, Pharmacyte Biotech Inc (OTCMKTS:PMCB) has confirmed the appointment of Linda S Sher as the company’s Chief Medical Officer. She joins the company as a professor of Clinical Surgery and Director of Clinical Research at the University Of Sothern California Keck School Of Medicine.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $PMCB and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Monica has an undergraduate degree in Accounting and an MBA she earned – with Honors. She has six years of experience in the financial markets and has been an analyst for the past two years.

Sunset Island Group Inc (OTCMKTS:SIGO)

Sunset Island Group Inc (OTCMKTS:SIGO) Expanding Production

Sunset Island Group Inc (OTCMKTS:SIGO)

Sunset Island Group Inc (OTCMKTS:SIGO) yesterday revealed that its cannabis grow space would be expanded. Initially the grow space will be increased to at least 152,000 square feet while still leaving room for more expansion later. The cannabis grower also disclosed that 6,000 square feet of grow space was already under construction. Consequently the stock price jumped by 33.33% to reach $1.12 in Wednesday’s trading.

Sunset Island Group Inc (OTCMKTS:SIGO)
One month SIGO stock price chart

At the same time the cannabis grower has revealed that MAPAL Agro supplies and equipment were being ordered to ensure that clones are planted in readiness for harvesting three months from now.

“The MAPAL Agro equipment and supplies are being ordered and set up and clones will be fully planted and ready for harvest approximately 90 days from now,” said the chief executive officer of Sunset Island Group, T.J. Magallanes in a statement.

Magallanes also provided detail on Sunset Island Group Inc (OTCMKTS:SIGO)’s business structure saying that they had set a realistic revenue target of approximately $200 for every square foot of cannabis planted. Sunset’s CEO said officers of the company, including himself, did not take salaries and they are solely compensated through a dividend that is paid monthly – just like what the shareholders receive. Currently Sunset Island Group has 4.7 million shares outstanding.

Preferred status shares

Magallanes added that shares belonging to officers are in preferred status and have a 36 month lock-in period starting from the day of any conversion. In order to expand, Sunset Island Group is looking to raise capital via an S-1 filing as well as converting into preferred shares a couple of substantial investments. The Chief Executive Officer of Sunset Island Group also revealed that the company held no real debt or even toxic debt and that would not change.

Due to the fact that the firm was harvesting rotationally, it is able to produce throughout the year. Sunset Island Group is also one of the cannabis grow facilities which have been awarded the Enviroganic Certification. Magallanes further revealed that shareholders can pay a visit to the firm for a tour on September 16, 2017.

The expansion of Sunset Island Group Inc (OTCMKTS:SIGO)’s grow space comes a little more than a week after the cannabis grower revealed that it was expecting a substantial rise in revenue from selling cannabis clones which are currently enjoying high demand in the state of California. Sunset projects it can sell 10,000 clones a month at the start and later increase to 50,000. Each clone costs between $5 and $10.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $SIGO and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Marc has a degree in economics and a MSc. in Finance. Over his 20-year career, Marc has worked for global investment firms in Europe and the United States as an analyst, fund manager, and consultant.

Amfil Technologies Inc (OTCMKTS:AMFE)

Amfil Technologies Inc (OTCMKTS:AMFE) Targets Cannabis Opportunities

Amfil Technologies Inc (OTCMKTS:AMFE)

Amfil Technologies Inc (OTCMKTS:AMFE) fell 5.07% after announcing that its subsidiary is in the process of finalizing roll-out plans for a 14,000 sq. ft. Canadian facility. The company is also fresh from announcing plans to reduce its share count by 300 million shares as it seeks to narrow the gap between authorized and outstanding share count.

The stock is currently trading in an upward trend having retreated from this year’s high of $0.23 a share. However, a recent sell-off wave threatens to push the stock lower after breaking a key support level at the $0.18. The stock faces immediate support at the $0.09 mark below which it could fall to $0.06 per share – just above this year’s lows of $0.01 a share.

Amfil Technologies Inc (OTCMKTS:AMFE)
One month AMFE stock price chart

Share Reduction

Amfil Technologies Inc (OTCMKTS:AMFE) is in the process of reducing the number of authorized shares from 900 million to 600 million as it seeks to shore up its market cap. The reduction should be complete by the end of the month. The company remains optimistic that starting Q3 2018, profits will be used to fund expansion plans instead of having to rely on stock issuance.

The reduction also underscores the company’s commitment to strengthening current shareholders value as the transaction will reduce stock dilution which should enhance investor confidence.

“The Company continues to move ahead with the recently announced acquisition of the cloud-based franchising software company and future acquisitions may potentially be done so by way of preferred stock to further this initiative,” Amfil Technologies Inc (OTCMKTS:AMFE) in a statement.

Cannabis Business

Separately, Amfil Technologies Inc (OTCMKTS:AMFE) continues to gain traction in pursuit of growth opportunities in the legal cannabis business. The company’s EcoPrO3 GRO3 Antimicrobial Systems as well as Roto-Gro Hydroponic Systems continue to elicit strong demand from a number of companies that are in the cannabis production business.

The company’s GR03 subsidiary is currently furnishing a quotation request received last month from a client who is planning to venture into the cannabis production business. A Roto-Gro representative is also working round the clock to provide the customer with an estimated number of units needed for a double stack roll-out at the 14,000 sq. facility.

In addition, Amfil Technologies Inc (OTCMKTS:AMFE)’s Snakes and Lattes subsidiary has also embarked on an expansion drive this time focusing on the South-East Asia and European markets. The tabletop gaming bar and café unit has already received orders from clients in the new markets.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $AMFE and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.

Terra Tech Corp (OTCMKTS:TRTC) Strengthens Operations

Terra Tech Corp (OTCMKTS:TRTC)

Terra Tech Corp (OTCMKTS:TRTC) has signed a non-binding letter of intent paving way for it to complete the acquisition of a 50% stake in NuLeaf Sparks Cultivation LLC and NuLeaf Reno Production LLC. The acquisition should strengthen the company’s cannabis cultivation and production portfolio allowing it to introduce new wholesale cannabis brands in the market.

Terra Tech Corp (OTCMKTS:TRTC)
One month TRTC Stock Price Chart

Investors Reaction

Investors reacted to the acquisition push, sending the stock up 10.19%. TRTC stock is currently trading in a tight $0.22 to $0.26 trading range, waiting to see if the bullish momentum is strong enough to push it to 52-week highs of $0.56 a share. Terra Tech faces resistance at the $0.26 mark.

Terra Tech Corp (OTCMKTS:TRTC) is a cannabis focused Agriculture Company that operates through Hydroponic produce and Cannabis products. The company designs, develops, and markets hydroponic equipment in addition to hydroponic produce and floral products.

NuLeaf Acquisition

The acquisition of NuLeaf Sparks should strengthen the company’s cultivation business given that the company owns a medical cannabis cultivation license. The firm is also in the process of constructing a 30,000 square foot cannabis cultivation facility in Nevada.

NuLeaf Reno holdings, on the other hand, should strengthen the company’s production business as it holds a cannabis production license and is in the process of constructing 15000 square foot facility. Terra Tech Corp (OTCMKTS:TRTC) CEO, Derek Peterson believes the merger will help the company become a dominant force in Nevada legal cannabis business.

“This partnership will allow us to rapidly increase our time to market without needing to invest vast amounts of time or CapEx into establishing cultivation and production capabilities from scratch,” said Mr. Peterson.

The executive remains confident of the transaction closing in the third quarter thus allowing Terra Tech Corp (OTCMKTS:TRTC) to start generating revenues from joint operations before the end of the year. The new cultivation and production facilities will supply three of the company’s dispensaries in addition to third-party dispensaries in the state.

Separately, Terra Tech Corp (OTCMKTS:TRTC) subsidiary Edible Green has expanded its product line with the introduction of a new line of fresh cut herbs dubbed ‘Snip Its’. The new line of product is to go on sale in major retail outlets that support health and wellness.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $TRTC and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Marc has a degree in economics and a MSc. in Finance. Over his 20-year career, Marc has worked for global investment firms in Europe and the United States as an analyst, fund manager, and consultant.

PotNetwork Holdings Inc (OTCMKTS:POTN) Robust Sales Growth

PotNetwork Holdings Inc (OTCMKTS:POTN)

Shares of PotNetwork Holdings Inc (OTCMKTS:POTN) continues to elicit renewed investor interest as the company’s subsidiary Diamond CBD continues to gain traction in the lucrative legal cannabis business. The unit continues to exceed expectations having achieved record breaking revenues of $1.5 million in June.

PotNetwork Holdings Inc (OTCMKTS:POTN) has been trading in an upward trend for the better part of the year. The stock is currently trading at the high end of a $0.07-$0.08 trading range as it closes in on its 52-week high of $0.10 a share. It faces resistance at the $$0.08 mark.

PotNetwork Holdings Inc (OTCMKTS:POTN)
One month POTN stock price chart

Sales Growth

Increased sales expectations in the company’s cannabis unit should continue to fuel interest from investors looking for opportunities in the cannabis business. As the legal cannabis business heats up PotNetwork Holdings Inc (OTCMKTS:POTN) is poised to see growth in demand for its products.

PotNetwork Holdings Inc (OTCMKTS:POTN) reported sales of $5 million for the first two-quarters of the year. Sales in the second quarter alone stood at $3.2 million representing a 1,495% year over year increase. Given the sales momentum, the company remains on track to exceed its full year sales forecast.

Net profit for the first six months of the year stood at $369,237 with a positive net cash flow of $395,009.

“We are consistently setting new sales records month after month and are excited to be able to report this type of continuing growth. We have taken our marketing efforts seriously. A commitment that is surely being revealed in the ongoing sales numbers,” stated Maria Gomez, Regional Vice President of Sales for Diamond CBD, Inc.

PotNetwork Holdings Inc (OTCMKTS:POTN) robust growth has already attracted interest from equity firms which have initiated coverage of the stock. SeeThruEquity analysts buoyed by the company’s sales growth momentum has initiated coverage with a share price target of $0.25 a share.

Board of Advisors Appointment

Separately, POTNETWORK HLDGS I COM USD0.0001 (POST REV SPLI (OTCMKTS:POTN) has moved to strengthen its board of advisors with the appointment of Mr. David Feldbaum. His appointment is part of an effort that seeks to strengthen the level of expertise that Diamond CBD will have exposure to, as it moves to come up with new formulations and product lines.

“We expect that his experience and wisdom will strengthen the Company’s position in the industry as we target product lines to enhance wellness in his areas of expertise,” states Maria Gomez, Regional Vice President of Sales for Diamond CBD.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $POTN and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.

CANNA CONSUMER GOO COM NPV (OTCMKTS:CBMJ)

CANNA CONSUMER GOO COM NPV (OTCMKTS:CBMJ)’s $500,000 Financing Rattles Investors

CANNA CONSUMER GOO COM NPV (OTCMKTS:CBMJ)

CANNA CONSUMER GOO COM NPV (OTCMKTS:CBMJ) shed 30% in market value after announcing it had secured a new $500,000 funding commitment, from MGH. The company plans to use the amount to increase its buying power of mainstream media as it moves to pursue new clients and expand its reach in the multibillion cannabis industry.

CANNA CONSUMER GOO COM NPV (OTCMKTS:CBMJ)
One month CBMJ stock price chart

Stock Performance

The new funding appears to have spooked investors as it increases the company’s debt holdings. Wednesday’s sell-off brought an end to the bullish run that began early in the month. The stock is currently trading in a $0.02-$0.03 trading range. It awaits to be seen if the stock will continue to edge lower or if the selloff is a minor pull back.

Canna Broadcast Media/ Loudmouth is an established mainstream media placement company with relationships in Radio, Print, TV and online media. The company produces cannabis-based content that air in over 700 radio stations globally.

Growing Client List

Under the terms of the agreement, MFG is to transfer the $500,000 financing in pre-paid media placement opportunities and services. The cannabis broadcasting company can use the media assignment on television, radio, and digital display to market products for its clients.

“By receiving $500,000 in media funding, CANNA CONSUMER GOO COM NPV(OTCMKTS:CBMJ) is now able to increase its buying power of mainstream media for the cannabis industry which is expected to increase our margins, expand our reach, and allow us to place media for a greater number of clients,” said CEO, Mark Schaftlein.

The chief executive officer expects the funding to put the company in a stronger financial position as it pursues high net worth clients in the cannabis business. Canna funding solutions is one of the companies that has already bought media placement in CBMJ DBA worth $100,000. The placements are to be used to promote companies that the firm plans to invest in at the upcoming MJAC217 Investorhub International cannabis conference

CANNA CONSUMER GOO COM NPV (OTCMKTS:CBMJ) has already partnered Investorhub to bring mainstream awareness to the upcoming Los Angeles Premium Investment cannabis event. The company was selected as the official partner as it is the only media company in the cannabis space with access to mainstream network media.

I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.

Don’t miss out! Stay informed on $CBMJ and receive breaking news on other hot stocks by signing up for our free newsletter!

About the author: Steve Clark is a 23-year Wall St professional with stints in M&A, risk management, and algorithm trading. Steve keeps his head in the game by looking for, and writing about, small companies that often get overlooked by the big investment firms.